Pfizer gene therapy for rare muscle disease shows promise in small, early study

Pfizer Inc on Friday presented promising results from a tiny early study of its experimental gene therapy for a rare muscle disease, but two of the six patients in the trial experienced side effects that landed them in the hospital.